Form 8-K - Current report:
SEC Accession No. 0001193125-25-060850
Filing Date
2025-03-24
Accepted
2025-03-24 07:01:21
Documents
17
Period of Report
2025-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d932759d8k.htm   iXBRL 8-K 30208
2 EX-99.1 d932759dex991.htm EX-99.1 95704
7 GRAPHIC g932759g0324055702146.jpg GRAPHIC 7806
8 GRAPHIC g932759g24c68.jpg GRAPHIC 13178
  Complete submission text file 0001193125-25-060850.txt   329934

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20250324.xsd EX-101.SCH 3100
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20250324_def.xml EX-101.DEF 13866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20250324_lab.xml EX-101.LAB 22897
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20250324_pre.xml EX-101.PRE 14704
19 EXTRACTED XBRL INSTANCE DOCUMENT d932759d8k_htm.xml XML 5888
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 25762194
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)